Allergan discloses economic impact of Cincinnati plant

Allergan’s pharmaceutical manufacturing and packaging plant in Oakley has a significant impact on the local region, according to a new study by the University of Cincinnati Economics Center.  The plant at 500 Brotherton Road employed 196 people in 2017 and resulted in total expenditures of $46.3 million when factoring in direct and indirect payroll as well as capital investments, according to the study commissioned by Allergan. The plant, which produces Vraylar (an antipsychotic drug approved for schizophrenia and bipolar mania) and Linzess (for irritable bowel syndrome with constipation), supports 686 total jobs directly and indirectly through local investment and operations. Direct earnings were $12 million in 2017, while indirect earnings for 424 jobs related to the Allergan plant’s operation generated $13.4 million. That totaled $25.5 million in earnings. Total expenditures were $34.7 million, including $18.3 million direct and $16.4 million indirect. Capital investment for the local plant was $5.5 million directly and $6.1 million indirectly for a total of $11.6 million. That generated 23 direct jobs with $1.5 million in earnings and 43 indirectly with $1.8 million in earnings.